Antipsychotic-induced weight gain is a major management problem for clinicians. It has
been shown that weight gain and obesity lead to increased cardiovascular and …

These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia …

Antipsychotic-related weight gain and metabolic effects are a critical outcome for patients
requiring these medications. A literature search using MEDLINE, Web of Science, PsycNET …

People with serious mental illness (SMI) have mortality rates 2 to 3 times higher than the
overall US population, largely due to cardiovascular disease. The prevalence of …

Background: Antipsychotic-induced metabolic adversities are often difficult to manage.
Using concomitant medications to counteract these adversities may be a rational option …

Metabolic syndrome with the atypical antipsychotics : Current Opinion in Endocrinology,
Diabetes and Obesity Metabolic syndrome with the atypical antipsychotics : Current Opinion in …

Despite variations across individuals and agents, antipsychotics are associated with clearly
documented weight gain and adverse metabolic effects. Although increased appetite/caloric …

Severe mental illness and obesity are each serious public health problems that overlap to a
clinically significant extent. Unfortunately, some of the most effective medications for severe …

The article critically reviews selected, clinically significant, adverse endocrine and metabolic
effects associated with psychotropic drug treatments, including hyperprolactinaemia …

Excessive bodyweight gain was reported during the 1950s as an adverse effect of typical
antipsychotic drug treatment, but the magnitude of bodyweight gain was found to be higher …